Default: Cancer Science

ISSN: 1347-9032

Journal Home

Journal Guideline

Cancer Science Q1 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Science is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 135. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2025 €. The scope of the journal is focused on oncology, cancer research, palliative care, radiotherapy. It has an SJR impact factor of 1,86 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

2025 €

Gold OA

-

Green OA

- €

Non OA

Metrics

Cancer Science

1,86

SJR Impact factor

135

H Index

365

Total Docs (Last Year)

924

Total Docs (3 years)

14020

Total Refs

4674

Total Cites (3 years)

907

Citable Docs (3 years)

4,99

Cites/Doc (2 years)

38,41

Ref/Doc


Best articles

A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells

View more

Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis

View more

Adult T-cell leukemia cells are characterized by abnormalities ofHeliosexpression that promote T cell growth

View more

Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm

View more

Antibody epitope peptides as potential inducers of IgG antibodies against CD98 oncoprotein

View more

Body iron stores and breast cancer risk in female atomic bomb survivors

View more

Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics

View more

c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo

View more

Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line

View more

Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients

View more

Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells

View more

Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-beta receptor inhibitor on extravasation of nanoparticles from neovasculature

View more
SHOW MORE ARTICLES

Contribution of autophagic cell death to p53-dependent cell death in human glioblastoma cell line SF126

View more

Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma

View more

Decrease of hepatic stellate cells in rats with enhanced sensitivity to clofibrate-induced hepatocarcinogenesis

View more

Deficiency of the Erc/mesothelin gene ameliorates renal carcinogenesis in Tsc2 knockout mice

View more

Development of a mouse model for lymph node metastasis with endometrial cancer

View more

Development of a risk prediction model for lung cancer: The Japan Public Health Center-based Prospective Study

View more

Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export

View more

Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity

View more

Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma

View more

Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4

View more

Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia

View more

Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis

View more

Comments

No comments ... Be the first to comment!